Philips Respironics pulled the products off the market in June 2021, and after about a year, 169 deaths were reported with a possible tie to the recall. Between Aug. 1 and Oct. 31 this year, that number has risen to 260 — a 54 percent increase — according to a Nov. 22 safety communication update.
In the reworked BiPAP and CPAP machines from Philips Respironics, there have been additional issues, including the foam breaking off from the device’s plastic backing and traces of particulate matter, which have been sent to third-party labs for testing.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
